Noven Pharmaceuticals, Inc. (NASDAQ:NOVN.DL)

KenN513 (88.53) Submitted: 7/13/2007 9:40:29 AM : Start Price: $19.89 NOVN.DL Score: -16.09

I found this stock on a Yahoo screener showing low PEG and good quick and current ratios. I think, though, that for the short term, "the Street" is continue to beat them up. Fool Brian Lawler say it best in his recent article:
"Visions of becoming the next Shire, Cephalon (Nasdaq: CEPH), or Endo Pharmaceuticals (Nasdaq: ENDP) surely cross the minds of executives of small specialty drugmakers once their products gain regulatory approval and the sales and royalty revenue start coming in. This often leads them to overpay when acquiring new products, or leads to share prices stagnating or declining if they just focus on in-house compounds. "
I would hold this investment until the next quarterly report sorts out the real costs and opportunities of a $125M investment in a $95M company.